Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Goldin

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2014
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsantNichole Coleman, Hai M Nguyen, Zhengyu Cao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 5, 2004
A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interactionJ Spampanato, J A Kearney, G de Haan, et al.
Clinical and Translational Science|December 11, 2024
An overview of drug-induced sodium channel blockade and changes in cardiac conduction: Implications for drug safetyKhuram W Chaudhary, Colleen E Clancy, Pei-Chi Yang, et al.
Neuron|January 6, 2001
Nomenclature of voltage-gated sodium channelsA L Goldin, R L Barchi, J H Caldwell, et al.
Journal of Research of the National Institute of Standards and Technology|June 17, 2016
Proposed Measurement of the Beta-Neutrino Correlation in Neutron DecayB Collett, R Anderman, S Balashov, et al.
Diabetes, Obesity & Metabolism|May 21, 2013
A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary careH Teoh, J-P Després, R Dufour, et al.
Epilepsia|June 9, 2016
SCN8A encephalopathy: Research progress and prospectsMiriam H Meisler, Guy Helman, Michael F Hammer, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2014
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsantNichole Coleman, Hai M Nguyen, Zhengyu Cao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 5, 2004
A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interactionJ Spampanato, J A Kearney, G de Haan, et al.
Clinical and Translational Science|December 11, 2024
An overview of drug-induced sodium channel blockade and changes in cardiac conduction: Implications for drug safetyKhuram W Chaudhary, Colleen E Clancy, Pei-Chi Yang, et al.
Neuron|January 6, 2001
Nomenclature of voltage-gated sodium channelsA L Goldin, R L Barchi, J H Caldwell, et al.
Journal of Research of the National Institute of Standards and Technology|June 17, 2016
Proposed Measurement of the Beta-Neutrino Correlation in Neutron DecayB Collett, R Anderman, S Balashov, et al.
Diabetes, Obesity & Metabolism|May 21, 2013
A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary careH Teoh, J-P Després, R Dufour, et al.
Epilepsia|June 9, 2016
SCN8A encephalopathy: Research progress and prospectsMiriam H Meisler, Guy Helman, Michael F Hammer, et al.
Pageof 13